PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Axonics, Inc. (AXNX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS05465P1012
CUSIP05465P101
SectorHealthcare
IndustryMedical Devices

Highlights

Market Cap$3.48B
EPS-$0.12
Revenue (TTM)$366.38M
Gross Profit (TTM)$197.67M
EBITDA (TTM)$7.78M
Year Range$47.59 - $69.68
Target Price$71.73
Short %6.24%
Short Ratio3.23

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AXNX

Axonics, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Axonics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%OctoberNovemberDecember2024FebruaryMarch
360.41%
93.76%
AXNX (Axonics, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Axonics, Inc. had a return of 10.83% year-to-date (YTD) and 23.14% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date10.83%10.16%
1 month0.97%3.47%
6 months21.00%22.20%
1 year23.14%30.45%
5 years (annualized)23.60%13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20249.08%0.09%
2023-5.09%-2.06%-8.75%9.33%11.14%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Axonics, Inc. (AXNX) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AXNX
Axonics, Inc.
0.59
^GSPC
S&P 500
2.79

Sharpe Ratio

The current Axonics, Inc. Sharpe ratio is 0.59. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
0.59
2.79
AXNX (Axonics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Axonics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-12.32%
0
AXNX (Axonics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Axonics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Axonics, Inc. was 61.24%, occurring on Mar 18, 2020. Recovery took 92 trading sessions.

The current Axonics, Inc. drawdown is 12.32%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-61.24%Jul 2, 2019180Mar 18, 202092Jul 29, 2020272
-49.78%Sep 8, 2021169May 9, 2022
-23.86%Mar 22, 201919Apr 17, 201915May 9, 201934
-20.57%Aug 6, 202023Sep 8, 202013Sep 25, 202036
-18.93%Dec 13, 201817Jan 8, 201927Feb 15, 201944

Volatility

Volatility Chart

The current Axonics, Inc. volatility is 1.79%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%OctoberNovemberDecember2024FebruaryMarch
1.79%
2.80%
AXNX (Axonics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Axonics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items